TAKING STOCK
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Shares of Boustead, with modest cleaning operations, will be suspended on Monday because it is regarded as a cash shell. Sir Thomas Macpherson, the chairman, complains the halt is not in "the best interest of the market, the company or the shareholders". After selling most of its interests Boustead is searching for acquisitions. The shares fell 0.5p to 16.5p.
Flare, a ceramics group, held at 139.5p. Australian David Lees, the chief executive, has met institutional investors this week. He is expanding the company with Ian Gowrie Smith, another Australian who was behind Medeva and is now developing SkyePharma. Stockbroker Greig Middleton believes Flare's profits will climb from pounds 800,000 to pounds 3m this year and pounds 5m next. It forecasts a 1p dividend this year.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments